Munteanu R, Moldovan C, Tigu A, Drula R, Feder R, Magdo L, Jurj A, Raduly L, Budisan L, Pirlog R, Moldovan A, Zimta A, Braicu C, Preda A, Munteanu V, Romitan M, Gulei D, Ciuleanu T. 5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity. Medicine and Pharmacy Reports [Internet]. 23Sep.2024 [cited 21Dec.2024];97(4):488-06. Available from: https://medpharmareports.com/index.php/mpr/article/view/2777